Edivoxetine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2018
02420122018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVE Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as… (More)
Is this relevant?
2015
2015
Inhibition of norepinephrine (NE) reuptake into noradrenergic nerves is a common therapeutic target in the central nervous system… (More)
Is this relevant?
2015
2015
Norepinephrine, a neurotransmitter in the autonomic sympathetic nervous system, is deaminated by monoamine oxidase to 3,4… (More)
Is this relevant?
2015
2015
OBJECTIVE The aim of this analysis was to assess the safety profile of edivoxetine as adjunctive treatment to selective serotonin… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2015
2015
OBJECTIVE When patients with major depressive disorder (MDD) are partial responders to antidepressant therapy, adjunctive… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2014
2014
OBJECTIVE The purpose of this study was to assess the efficacy and safety of edivoxetine (LY2216684), a selective norepinephrine… (More)
Is this relevant?
2014
2014
BACKGROUND This phase 2 study examined the efficacy and tolerability of edivoxetine, a highly selective norepinephrine reuptake… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
OBJECTIVE The purpose of this study was to assess the clinical outcomes from an open label study of edivoxetine, a selective… (More)
Is this relevant?
2013
2013
To assess the impact of hepatic or renal impairment on the pharmacokinetics (PK) of edivoxetine. Two separate multi-center, open… (More)
  • figure 1
  • figure 4
  • figure 2
  • figure 3
Is this relevant?
2012
2012
OBJECTIVE Edivoxetine (LY2216684) is a selective and potent norepinephrine reuptake inhibitor (NERI). The pharmacokinetics (PK… (More)
Is this relevant?